Finance

Lists
Why is KRRO down 6.61%?
Dive Deeper
KRRO:NASDAQ
Korro Bio Inc
$12.71
-6.61%
(-0.90) 1D
$12.71
0.00% (0.00)
After hours
Closed: Nov 16, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
$13.44
High
$13.61
Low
$12.60
Mkt. cap
174.45M
Avg. vol.
215.42K
Volume
0.00
52-wk high
$17.35
52-wk low
$5.20
EPS
-$9.06
Beta
3.23
Shares outstanding
13.73M
No. of employees
58
Open
$13.44
High
$13.61
Low
$12.60
Mkt. cap
174.45M
Avg. vol.
215.42K
Volume
0.00
52-wk high
$17.35
52-wk low
$5.20
EPS
-$9.06
Beta
3.23
Shares outstanding
13.73M
No. of employees
58
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees58
Founded2014
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 6 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current $12.71
$30.00 (+136.03%)
Average
$19.83 (+56.02%)
Lowest
$10.00 (-21.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Hold
Maintained
$10.00
-21.3%
11/05/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$21.00
+65.2%
11/05/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$15.00
+18%
11/06/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$22.00
+73.1%
10/28/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$30.00
+136%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
$21.00
+65.2%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$22.00
+73.1%
10/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$22.00
+73.1%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
$18.00
+41.6%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$15.00
+18%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
$23.00
+81%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
$23.00
+81%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.29M
-
-
-
Cost of goods sold
8.60M
11.53M
11.63M
10.16M
Cost of revenue
8.60M
11.53M
11.63M
10.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.58M
8.91M
8.48M
8.29M
Operating expense
8.58M
8.91M
8.48M
8.29M
Total operating expenses
17.18M
20.44M
20.11M
18.46M
Operating income
-15.88M
-20.44M
-20.11M
-18.46M
Other non operating income
990.00K
-
-
-
EBT including unusual items
-49.41M
-19.53M
-18.81M
-17.29M
EBT excluding unusual items
-14.89M
-19.53M
-18.81M
-17.29M
Income tax expense
636.00K
95.00K
108.00K
260.00K
Effective tax rate
-1.29%
-0.49%
-0.57%
-1.50%
Other operating expenses
-
-
-
-
Net income
-50.04M
-19.62M
-18.92M
-17.55M
Net profit margin
-3,873.22%
-
-
-
Earnings per share
-1.65
-1.69
-1.07
-0.98
Interest and investment income
-
906.00K
1.30M
1.17M
Interest expense
-
-
-
-
Net interest expenses
-
906.00K
1.30M
1.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.23M
-20.06M
-19.74M
-18.10M
Gain or loss from assets sale
-18.00K
-
-
7.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps